Label

How We Work

Grant

Back

Print

Dana-Farber Cancer Institute


May 2009
to develop a new vaccine platform for HIV based on the hypothesis that immunodominant regions of the virus may be irrelevant to neutralizing the virus and also prevent access to neutralizing epitopes in conserved regions
$100,000
18
Discovery and Translational Sciences
Global Health
Boston, Massachusetts

Visit Our Blog